The utility of copy number variation (CNV) in studies of hypertension-related left ventricular hypertrophy (LVH): Rationale, potential and challenges
The ultimate goal of human genetics is to understand the role of genome variation in elucidating human traits and diseases. Besides single nucleotide polymorphism (SNP), copy number variation (CNV), defined as gains or losses of a DNA segment larger than 1 kb, has recently emerged as an important to...
Published in: | Molecular Cytogenetics |
---|---|
Main Author: | Boon-Peng H.; Yusoff K. |
Format: | Review |
Language: | English |
Published: |
BioMed Central Ltd.
2013
|
Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85040956304&doi=10.1186%2f1755-8166-6-8&partnerID=40&md5=5583275bb21358787182d473b93566b6 |
Similar Items
-
Novel population specific autosomal copy number variation and its functional analysis amongst Negritos from Peninsular Malaysia
by: Mokhtar S.S.; Marshall C.R.; Phipps M.E.; Thiruvahindrapuram B.; Lionel A.C.; Scherer S.W.; Peng H.B.
Published: (2014) -
Optimal Exercise-Based Rehabilitation Characteristic in Improving Peak VO2 and Left Ventricular Ejection Fraction (LVEF) on Patients with Coronary Artery Disease (CAD): A Systematic Review and Meta-analysis
by: Azlan D.Z.B.; Ramlan N.Q.B.; Mustafa M.A.; Mutalib N.F.A.; Adnan R.; Pheng L.C.; Razak M.N.A.; Malek K.A.; Ismail H.
Published: (2024) -
Variations in knowledge, awareness and treatment of hypertension and stroke risk by country income level
by: O'Donnell M.; Hankey G.J.; Rangarajan S.; Chin S.L.; Rao-Melacini P.; Ferguson J.; Xavier D.; Lisheng L.; Zhang H.; Pais P.; Lopez-Jaramillo P.; Damasceno A.; Langhorne P.; Rosengren A.; Dans A.L.; Elsayed A.; Avezum A.; Mondo C.; Smyth A.; Judge C.; Diener H.-C.; Ryglewicz D.; Czlonkowska A.; Pogosova N.; Weimar C.; Iqbal R.; Diaz R.; Yusoff K.; Yusufali A.; Oguz A.; Wang X.; Penaherrera E.; Lanas F.; Ogah O.S.; Ogunniyi A.; Iversen H.K.; Malaga G.; Rumboldt Z.; Oveisgharan S.; Alhussain F.; Daliwonga M.; Nilanont Y.; Yusuf S.
Published: (2021) -
Rationale and design of a cluster randomized trial of a multifaceted intervention in people with hypertension: The Heart Outcomes Prevention and Evaluation 4 (HOPE-4) Study
by: Schwalm J.-D.R.; McCready T.; Lamelas P.; Musa H.; Lopez-Jaramillo P.; Yusoff K.; McKee M.; Camacho P.A.; Lopez-Lopez J.; Majid F.; Thabane L.; Islam S.; Yusuf S.
Published: (2018) -
Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) Trial
by: Bosch J.; Eikelboom J.W.; Connolly S.J.; Bruns N.C.; Lanius V.; Yuan F.; Misselwitz F.; Chen E.; Diaz R.; Alings M.; Lonn E.M.; Widimsky P.; Hori M.; Avezum A.; Piegas L.S.; Bhatt D.L.; Branch K.R.H.; Probstfield J.L.; Liang Y.; Liu L.; Zhu J.; Maggioni A.P.; Lopez-Jaramillo P.; O'Donnell M.; Fox K.A.A.; Kakkar A.; Parkhomenko A.N.; Ertl G.; Störk S.; Keltai K.; Keltai M.; Ryden L.; Dagenais G.R.; Pogosova N.; Dans A.L.; Lanas F.; Commerford P.J.; Torp-Pedersen C.; Guzik T.J.; Verhamme P.B.; Vinereanu D.; Kim J.-H.; Ha J.-W.; Tonkin A.M.; Varigos J.D.; Lewis B.S.; Felix C.; Yusoff K.; Steg P.G.; Aboyans V.; Metsarinne K.P.; Anand S.S.; Hart R.G.; Lamy A.; Moayyedi P.; Leong D.P.; Sharma M.; Yusuf S.
Published: (2017)